We are proud to present the winners of our first annual PM360 ELITE Awards. The ELITE (Exceptional Leaders, Innovators, Transformers and Entrepreneurs) represent the most influential people in the healthcare industry. The key word: People. This is PM360’s first award to focus solely on people—not just their work or company—but the individual.

We shine a spotlight on the most powerful minds—the thinkers who are shaping our industry. But beyond that, we provide our readers with insights into how these exceptional individuals became so successful—highlighting their greatest accomplishments, current game-changing projects and goals for the future. We also offer all of pharma the opportunity to rub elbows with this eclectic group as we honor the PM360 ELITE with an awards cocktail party, July 14th at 6:30 PM at the Standard High Line rooftop bar in New York City’s Meatpacking District.

But first, meet PM360’s ELITE inaugural class. These 60 individuals are not simply the top people in their fields—but also the industry’s preeminent leaders. And it was not easy to narrow the field down to just 60. We received a large number of nominations—from every area of the industry—that were not only compelling but brimming with enthusiasm. The nominations were more than just facts and figures detailing a person’s vast accomplishments, but passionate testimonials stressing why that person was so deserving of being honored. But ultimately we choose the 60 that represented the true crème de la crème.

And that starts with PM360’s Uber Elite—or the very best of the very best—Brenton “Brent” Saunders, the CEO of Actavis. At just 44, his accomplishments are numerous. He served as the CEO of three major pharma companies and just recently transformed Actavis—through the acquisition of Allergan—from a generics manufacturer into a top 10 company.

We also honor the ELITE in the following 12 categories:

Leaders of the Future: Up-and-comers who display the characteristics of an emerging leader.

Entrepreneurs: Visionary risk-takers who develop new companies to answer unmet needs.

Transformational Leaders: People who change the way companies operate—from instituting new organizational structures to reinvigorating stagnant businesses.

Patient Advocates: Those who work on patients’ behalf to make their voices heard and ensure their needs are met.

Disrupters: The fearless individuals who disrupt the status quo to revolutionize the industry.

Mentors: The role models others aspire to emulate.

Strategists: People with a sixth sense for what works—and the ability to predict what the evolving pharma industry needs to do to remain relevant.

Tech-know Geeks: Innovators who spearhead technological breakthroughs that reshape the industry.

Master Educators: People who revolutionize the way patients/doctors learn and absorb the information available from life science companies.

Data Miners: Individuals who specialize in analytics and can turn hordes of numbers and research into actionable insight.

Launch Experts: Marketers with significant success in bringing a new drug to market or in revitalizing markets for an older drug with a fresh campaign.

Digital Crusaders: Those who advance digital channel applications or platforms to transform marketing and/or company operations.

Dive in and learn what it takes to become ELITE.

The 2015 Elite Winners

Uber Elite

Brenton “Brent” Saunders, Actavis

Leaders of the Future

Greg Cohen, UCB, Inc.

Tom Fussaro, Astellas Pharma US, Inc.

Meredith S. Manning, Baxter BioScience

Michael Nesrallah, Novartis Pharmaceuticals Corporation

Jeenal Shah, Sudler New York

Jeremy T. Shepler, Novo Nordisk Inc.


Charles Benaiah, watzan

Mark Heinold, PDR, LLC

Jeff Meehan, Cancer Action Now

Robert G. Previdi, PSKW, LLC

Frank Segrave, Silvergate Pharmaceuticals, Inc.

Transformational Leaders

Matt Giegerich, Ogilvy CommonHealth Worldwide

Kim Johnson, PALIO

Melissa Johnston, Benchworks

Michelle Keefe, Publicis Touchpoint Solutions, Inc.

Meghan Lopresto, Boehringer Ingelheim

Anthony J. Maddaluna, Pfizer Inc. and Pfizer Global Supply

David Nakamura, Natrel

Hugh O’Neill, Mallinckrodt

Frank X. Powers, Dudnyk

Scott Shively, Depomed, Inc.

Donato Tramuto, Physicians Interactive

Timothy P. Walbert, Horizon Pharma plc

Robert Ward, Radius Health, Inc.

Patient Advocates

Lene Andersen, HealthCentral – Remedy Health Media

Karen Iannella, Boehringer Ingelheim Pharmaceuticals Inc.

Doug Ulman, Pelotonia


Michael Coffey, Roche Diabetes Care Inc.

Jim Curtis, Remedy Health Media

Elizabeth Elfenbein, The CementBloc

Peter Kirk, SERMO

Ibraheem (Ibs) Mahmood, DrugDev

Stan Woodland, CMI/Compas


Thomas P. McDonnell, Shire Pharmaceuticals, Inc.

Claire Scott, Genentech

Shilpa Shah-Mehta, Novartis Oncology

Gwen D. Washington, Shire Pharmaceuticals, Inc.

Deborah Wood, DWA Healthcare Communications Group and Avant Healthcare


Matt Barry, Astellas Pharma US, Inc.

Jay Carter, AbelsonTaylor

Danielle Dunne, Allidura Consumer, part of inVentiv Health

Jesus Leal, Novartis

Mario R. Nacinovich Jr., MSc, AXON

Danny Villeneuve, Shire

Tech-know Geeks

Kendra Fanara, Janssen Therapeutics

Adam Kaplin, MD, PhD, Johns Hopkins University School of Medicine

David Windhausen, Intouch Solutions

Pasqual Zottola, Acorda Therapeutics, Inc.

Master Educator

Paula van de Nes, PhD, LLNS

Data Miners

Malcolm Bohm, Liquid Grids Inc.

Asaf Evenhaim, Crossix Solutions

Manish Sood, Reltio, Inc.

Launch Experts

David Green, RPh, Bausch & Lomb, Inc., A Valeant Pharmaceuticals North America LLC Company

Jonathan Kuhn, Acorda Therapeutics, Inc.

Andrew J. Watson, Wockhardt USA

Digital Crusaders

Dave Guiga, AstraZeneca

Trish Nettleship, UCB, Inc.

Nancy Phelan, Bristol-Myers Squibb

Michael Russo, Acorda Therapeutics, Inc.


You May Also Like

How Pharma Companies Can Ensure They Are Getting the Most Out of HEOR

With increasing pressure on pricing and the focus on health outcomes and value-based care, ...